Bispectral Index(BIS) on Depth of Sedation With Dexmedetomidine, Propofol and Midazolam During Spinal Anesthesia

• Status: Unknown status
• Trial end date: 2018-03-31
• Target enrollment: 0
• Participant gender: All

Summary

This study is to investigate on the objective relevance between bispectral index (BIS) and Observer's assessment of alertness/sedation (OAA/S) scale in patients sedated with Midazolam, propofol and dexmedetomidine during spinal anesthesia. Also, we will evaluate the reflection of actual sedation levels on BIS monitoring.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hallym University Medical Center
• Treatments: Dexmedetomidine; Midazolam; Propofol

Criteria

Inclusion Criteria:

• Patients who scheduled for knee arthroscopic surgery under spinal anesthesia

Exclusion Criteria:

• Patients with a history of hepatic, renal, cardiovascular disease, and those who have allergy to study drugs (dexmedetomidine, propofol, midazolam).

• Hemodynamically unstable patients.

• Patients who is noncommunicative.